Brain Scientific Inc. (BRSF) Joins Forces with JelikaLite to Reduce Symptoms of Autism
BRSF and JelikaLite have joined forces in a clinical trial for reducing autism symptoms in children JelikaLite uses PRM therapy to reduce autism symptoms BRSF sees this as an important step forward in wider adoption of affordable, accessible EEG systems The neurology-focused medical device and software company Brain Scientific (OTCQB: BRSF) announced on March 16, 2021, it is collaborating with JelikaLite in a clinical trial. The clinical trial, which began in March 2021, is designed to potentially uncover new treatment options to reduce autism symptoms in children. The trial has 30 participants from two New York City locations. JelikaLite was…